Brainsway (BRSYF) Cash from Financing Activities (2025 - 2026)
Brainsway posted quarterly Cash from Financing Activities of -$901000.0 for Q1 2026, down 19.34% year-on-year from -$1.1 million in Q1 2025, and down 19.34% on a QoQ basis from -$755000.0 in Q1 2025.
Brainsway (BRSYF) has 2 years of Cash from Financing Activities data on file, last reported at -$901000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Brainsway | - | - | 11.68 Mn | -901,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -901,000.00 |
| Mar 31, 2026 | -901,000.00 |
| Mar 31, 2025 | -755,000.00 |
| Mar 31, 2025 | -755,000.00 |